Beyond Celiac is the leading trusted resource on celiac disease. We are available and qualified to speak to the press on a variety of topics including, but not limited to:
Celiac disease as a serious genetic autoimmune disease
Health equity in celiac disease
Celiac disease patient advocacy and patient stories
The need for treatments beyond the gluten-free diet
The latest in celiac disease research/science/drug development
Non-GI symptoms of celiac disease
Connection to other autoimmune diseases
Growth of the gluten-free market, gluten-free labeling
If you are a member of the media, such as a journalist, blogger, etc., and want to know more about Beyond Celiac, including our research program, Science Plan, patient stories, and more, please contact Beyond Celiac Director of Communications, Claire Baker, at 215-325-1306 ext 111 or [email protected].
For more information on Beyond Celiac, celiac disease and the gluten-free diet:
About Beyond Celiac
Download CEO Alice Bast’s Headshots
Beyond Celiac Brand Elements/Logos
Beyond Celiac Science Plan
Download the Gluten-Free Diet Handout
Download What is Celiac Disease?
Voices of Celiac Disease Patient Stories
Fast Facts about Celiac Disease
Biotech, pharma, and diagnostic industry come together with clinicians and scientists to overcome patient barriers in clinical trials
Han will use the $180,000 grant to investigate the role of CD8 T-cells in celiac disease
Podcast Recording of Recent Virtual Town Hall Series Is Now Available
Beyond Celiac announced that Ed Lewin, Vice President of Government & Public Affairs at the LEGO Group, has been elected to the organization’s Board of Directors.
Virtual Step Beyond Celiac 5K offers connection, support for research
The $209,000 Established Investigator Grant award will expand understanding of effects of gluten on the brains of people with celiac disease
“Just before his third birthday, Max had dropped so much weight that he was back to wearing his one-year-old clothes.”
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to